Jinan Hongyuan Chemical Co.,Ltd

Jinan Hongyuan Chemical Co.,Ltd

86-13954187575

Jinan Hongyuan Chemical Co.,Ltd
홈페이지> 블로그
April 07, 2022
What are the uses of food additives?

What are food additives? According to the Food Hygiene Law of China (1995) , food additives are synthetic or natural substances added to food for the purpos

April 06, 2022
What are the applications of Sodium methoxide?

Sodium methoxide, also known as Sodium methoxy, Sodium methoxide, English name: Sodium methoxide, Molecule CH3NaO, CAS no: 124-41-4, dangerous chemical, corrosive, natural, etc

April 01, 2022
What is this coenzyme Q10 that everyone is talking about?

A side effect of coq10? Is COENZYME Q10 the I.Q. tax? Is COENZYME Q10 that good? CO

March 04, 2022
The first aerospace coenzyme Q10 terminal product in China began to enter the civilian market

"In 5 to 10 years, the raw materials currently used for the production of lithium-ion batteries will be exhausted." In the Future Energy Development Forum at the World's Top Scientists Carbon Conferen

March 03, 2022
China's pharmaceutical raw material drug market: export rational warming

Faced with the huge market opportunities of global generic drugs and the huge demand of high-end markets in Europe, the United States and Japan, many domestic raw materia

February 21, 2022
Two new drugs are included in the proposed priority review varieties! From Hengrui Pharmaceutical, Jinsai Pharmaceutical

On October 12, according to the announcement of the Center for Drug Evaluation (CDE) of the National Medical Products Adm

January 18, 2022
The authoritative department does not cause any harm to the human body by rational use of food additives for food additives.

All food safety incidents that have occurred in recent years are not caused by food additives. The rational use of food additives does not cause harm to the human body. This is the information that th

January 06, 2022
Customs codes of some vitamin products have been changed

According to the customs and various factories, from December 31, 2021, the old customs code 2936290090 will be deactivated under the trade name of other unmixed vitamins

January 05, 2022
Sinopharm Hyundai's "universal antioxidant" lipoic acid API was approved in India and South Korea

Beijing News (Reporter Zhang Zhaohui) On December 15th, Sinopharm Hyundai announced that its wholly-owned subsidiary Sinopharm Weiqida's lipoic acid APIs have obtained the API registration certificate

January 04, 2022
The first aerospace coenzyme Q10 terminal product in China began to enter the civilian market

China's aerospace technology application industry has made gratifying progress. On March 30th, the reporter learned from the “Space Aeronautical Technology Application Ac

December 22, 2021
In the production of non-woven fabrics, what is the difference between large chemical fiber, medium chemical fiber, and small chemical fiber?

Large chemical fiber: CHEMICAL FIBER  Staple fibers spun with PET chips or melt-spun directly ha

December 21, 2021
Glutathione Peroxidase (GSH-PX) Assay Kit Instructions

Glutathione Peroxidase (GSH-PX) Test Box Specification I. Experimental apparatus: test tube, micropipette, vortex mixer, centrifuge, 37°C constant temperature water bath, visible spectrophotometer (w

December 20, 2021
From aromatics to aromatic amines: new breakthroughs in the use of bulk chemical raw materials

As an important chemical raw material, aniline is widely used in dyes, medicines, pesticides, explosives, rubber vulcanization accelerators and other fields. At present, the global demand for an

December 17, 2021
Regulate the industry development of raw material drug drying process must be strictly in accordance with GMP requirements

Drying in raw material production is a common operation. Drying with intermediates also has finished drying. Therefore drying equipment appears to be crucial in the pharm

November 05, 2021
Sansheng Guojian PD-1 monoclonal antibody combined with initumab for the treatment of solid tumors was approved for phase Ib/II clinical trials

On November 2, China's antibody drug pioneer Sansheng Guojian (stock code: 688336) announced that the company has recently rece

November 02, 2021
The new drug is derailed! Top 10 drug distribution

Best or Worst, the true success of a new drug de

October 30, 2021
Qin Hao Pharmaceutical's new SHP2 inhibitor clinical trial application was approved in the U.S.

Recently, Qinhao Pharmaceutical announced that its strategic partner Huya Bio-International has submitted a new drug clinical t

October 27, 2021
Hengrui PD-1 monoclonal antibody combined with Famitinib for the treatment of non-small cell lung cancer phase III clinical approval

On October 26, Hengrui Pharmaceuticals announced that it had obtained the "Notice of Drug Clinical Trial Approval" approved and issued by the National Medical Produ

October 26, 2021
The first in the world! Heji Pharmaceuticals ITK Inhibitor Approved for Clinical

On October 26, 2021, Heji Pharmaceuticals announced that the world’s first ITK inhibitor to enter the clinical development st

October 23, 2021
Simcere's breast cancer innovative drug SIM0270 (SCR-6852) clinical trial application accepted

On October 21, 2021, the clinical trial application for the innovative breast cancer drug SIM0270 (SCR-6852) independentl

October 21, 2021
Benefiting from centralized procurement and relying on a single product, Huiyu Pharmaceutical will soon be listed on the Sci-tech Innovation Board. What is the potential?

On October 18, Huiyu Pharmaceutical issued a prospectus for listing on the Science and Technology Innovation Board. Its initial public offering of shares began on O

October 18, 2021
Ganli Pharmaceutical Insulin Glargine (GL-GLA) completed overseas Phase III clinical study

Beijing, China/Bridgewater, New Jersey, USA, October 14, 2021-Ganli Pharmaceutical Co.,

October 15, 2021
ECTRIMS Conference丨Roche, Sanofi, Bojian and many other pharmaceutical companies announce the latest clinical data of multiple sclerosis drugs

Multiple sclerosis (MS) is a disabling disease of the central nervous system that affects more than one million Americans. The

October 14, 2021
Galenwolizumab is clinically active in the treatment of hepatitis B IIa

Hangzhou, China and Shaoxing, October 12, 2021--Gallite Pharmaceutical Co., Ltd. (Hong Kong Stock Exchange code: 1672) today announced its sub

홈페이지

Product

Whatsapp

우리에 대해

문의

We will contact you immediately

Fill in more information so that we can get in touch with you faster

Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.

송신